These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23342679)

  • 1. Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial.
    Shackley P; Shaw L; Price C; van Wijck F; Barnes M; Graham L; Ford GA; Steen N; Rodgers H
    Toxins (Basel); 2012 Dec; 4(12):1415-26. PubMed ID: 23342679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for the economic evaluation of the InTENSE program for rehabilitation of chronic upper limb spasticity.
    Milte R; Ratcliffe J; Ada L; English C; Crotty M; Lannin NA
    BMC Health Serv Res; 2020 May; 20(1):478. PubMed ID: 32460773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of onabotulinumtoxinA for the treatment of wrist and hand disability due to upper-limb post-stroke spasticity in Scotland.
    Doan QV; Gillard P; Brashear A; Halperin M; Hayward E; Varon S; Lu ZJ
    Eur J Neurol; 2013 May; 20(5):773-80. PubMed ID: 23278954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity.
    Ward A; Roberts G; Warner J; Gillard S
    J Rehabil Med; 2005 Jul; 37(4):252-7. PubMed ID: 16024483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Rodgers H; Shaw L; Price C; van Wijck F; Barnes M; Graham L; Ford G; Shackley P; Steen N;
    Trials; 2008 Oct; 9():59. PubMed ID: 18947418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M; Brand C; Louie J; Khan F
    J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
    Danchenko N; Johnston KM; Whalen J
    J Med Econ; 2022; 25(1):919-929. PubMed ID: 35730362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Faux SG; Palit M; Gonzalez S; Olver J; Cameron I; Crotty M;
    Stroke; 2020 Feb; 51(2):556-562. PubMed ID: 31813359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: Protocol for the InTENSE trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Crotty M
    Int J Stroke; 2018 Aug; 13(6):648-653. PubMed ID: 29553309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.
    Johnston K; Danchenko N; Hansen R; Dinet J; Liovas A; Armstrong A; Bains S; Sullivan SD
    J Med Econ; 2020 Jun; 23(6):631-640. PubMed ID: 31985313
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
    Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
    J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color Doppler ultrasound-guided botulinum toxin type A injection combined with an ankle foot brace for treating lower limb spasticity after a stroke.
    Ding XD; Zhang GB; Chen HX; Wang W; Song JH; Fu DG
    Eur Rev Med Pharmacol Sci; 2015; 19(3):406-11. PubMed ID: 25720711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.